Sun Pharma Advanced Research Company Ltd (SPRC.NS)

SPRC.NS on National Stock Exchange of India

3:59pm IST
Change (% chg)

Rs0.60 (+0.15%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Sun Pharma Advanced Research June-qtr loss widens
Friday, 29 Jul 2016 

Sun Pharma Advanced Research Company Ltd : June-quarter net loss 364.1 million rupees versus loss of 16.5 million rupees last year . June-quarter total income from operations 214.8 million rupees versus 434.4 million rupees last year .  Full Article

Sun Pharma and Almirall signs license deal for Psoriasis treatment
Thursday, 28 Jul 2016 

Sun Pharmaceutical Industries Ltd : Almirall and Sun Pharma enter into a license agreement for Tildrakizumab in Europe for Psoriasis . To receive development & regulatory milestone payments, royalties, the terms of which are confidential .  Full Article

Almirall signs license deal with Sun Pharma for psoriasis treatment
Wednesday, 27 Jul 2016 

Almirall SA : Says enters into a license agreement with Sun Pharma Industries for tildrakizumab in Europe for psoriasis . Says to pay Sun Pharma an initial upfront payment of $50 million . Says Sun Pharma will be eligible to get milestone payments, sales milestone payments and royalties on net sales .Says phase-3 studies of tildrakizumab have recently been completed.  Full Article

Sun Pharma Advanced Research March-qtr net loss widens
Friday, 6 May 2016 

Sun Pharma Advanced Research Company Ltd : March quarter net loss 95.8 million rupees versus loss of 94 million rupees . March quarter total income from operations 411.7 million rupees versus 427 million rupees .  Full Article